secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2023-12-27T23:59:59+00:00
Accession:  0001753926-23-001644
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------

- Nasdaq notified Vivani on Dec 26, 2023 that common stock closed below $1.00 for 30 consecutive trading days through Dec 21, 2023.
- Company has 180 days (until June 24, 2024) to regain compliance by maintaining $1.00 closing bid price for at least 10 consecutive trading days.
- If not compliant by June 24, 2024, Vivani may be eligible for an additional 180-day period if it meets other listing standards and intends to cure (e.g., reverse stock split).
- Failure to regain compliance could lead to delisting; Vivani may appeal any delisting determination to a Nasdaq Hearings Panel.
- Vivani intends to monitor bid price and may consider actions including a reverse stock split, subject to board and stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392623001644/0001753926-23-001644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392623001644/g083900_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer